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ABSTRACT
Facial form depends on the precise positioning of cartilage, bone, and
tooth fields in the embryonic pharyngeal arches. How complex
signaling information is integrated to specify these cell types remains
a mystery. We find that modular expression of Forkhead domain
transcription factors (Fox proteins) in the zebrafish face arises through
integration of Hh, Fgf, Bmp, Edn1 and Jagged-Notch pathways.
Whereas loss of C-class Fox proteins results in reduced upper facial
cartilages, loss of F-class Fox proteins results in distal jaw truncations
and absent midline cartilages and teeth. We show that Fox proteins
are required for Sox9a to promote chondrogenic gene expression.
Fox proteins are sufficient in neural crest-derived cells for cartilage
development, and neural crest-specific misexpression of Fox proteins
expands the cartilage domain but inhibits bone. These results support
a modular role for Fox proteins in establishing the competency of
progenitors to form cartilage and teeth in the face.
KEYWORDS: Forkhead, Foxc1, Foxf1, Foxf2, Sox9, Cartilage, Teeth,
Bone, Pharyngeal arches, Craniofacial, Zebrafish
INTRODUCTION
Development of the vertebrate head skeleton involves the
specification of cartilage, bone, tooth and other connective tissue
fates in reproducible, interconnected positions. The progenitors for
these skeletal cells derive from the head paraxial mesoderm and a
specialized population of cranial neural crest-derived cells (CNCs).
In the pharyngeal arches, CNCs are exposed to diverse extracellular
signals that regulate skeletal differentiation. Endothelin 1 (Edn1),
Bone morphogenetic protein (Bmp) and Jagged-Notch signaling
interact to generate nested gene expression patterns along the
dorsoventral/proximodistal arch axis, which help direct particular
morphologies of cartilages and bones in the upper versus lower face
(Zuniga et al., 2010, 2011; Alexander et al., 2011). In contrast,
Hedgehog (Hh) and Fibroblast growth factor (Fgf) signaling are
largely dispensable for dorsoventral gene expression, instead
playing crucial roles in CNC proliferation, survival and
differentiation (Balczerski et al., 2012). Given that many of the
target genes for these pathways are expressed in broader domains
than the precursor regions for individual skeletal elements
(Medeiros and Crump, 2012), a central mystery is how complex
signaling information is integrated to specify individual cartilages,
bones and teeth.
Fox genes are a large family of transcription factors that share a
highly conserved winged-helix/forkhead DNA-binding domain yet
little conservation otherwise (Hong et al., 1999). During murine
craniofacial development, CNC expression of Foxc1, Foxc2, Foxd1,
Foxd2, Foxf1 and Foxf2 is positively regulated by Hh signaling,
with their distinct arch expression domains leading to the proposal
that Fox genes might constitute a code for facial skeletal
development (Yamagishi et al., 2003; Jeong et al., 2004). In
support of this, Foxc1mutant mice display loss of the calvarium and
increased ossification of the mandible, squamosal and zygomatic
bones, leading to jaw fusion (syngnathia) (Hong et al., 1999; Kume
et al., 2001; Inman et al., 2013); Foxc2 mutant mice develop cleft
palate, defective pterygoquadrate cartilage development, and
fusions of the middle ear bones (Iida et al., 1997); and Foxf1 and
Foxf2 mutants display cleft palate (Wang et al., 2003; Xu et al.,
2016). In humans, mutations in FOXC1 have been linked to the
craniofacial and ocular defects of Axenfeld–Rieger syndrome
(Mears et al., 1998; Fang et al., 2000). Foxf1 and Foxf2 are also
prominently expressed in developing tooth buds (Wang et al.,
2003), though a genetic requirement has yet to be identified.
Whether Fox proteins broadly control regional facial skeletal fates,
as well as their mechanisms of action, remains unclear.
Although examination of Fox-C and Fox-F genes in the
mammalian face point to requirements in bone and palate
formation, clues to potential mechanisms come from analysis of
their roles in the appendicular and axial skeletons. The spontaneous
congenital hydrocephalusmouse mutant carries a point mutation in
Foxc1 and has defects in sternal chondrogenesis. In particular,
cultured mesenchymal cells from mutants fail to differentiate into
cartilage, even upon exposure to BMP2 (Kume et al., 1998). Foxc1
mutants also display delayed endochondral ossification of the
femur, in part owing to normal binding of a Foxc1-Gli2 complex to
promoters of the chondrocyte genes Col10a1 and Pthrp (Pthlh ̶
Mouse Genome Informatics) (Yoshida et al., 2015). Sox9 is an
essential regulator of cartilage differentiation, with loss of Sox9 in
mouse or sox9a in zebrafish resulting in a near-complete absence of
cartilage (Bi et al., 1999; Akiyama et al., 2002;Mori-Akiyama et al.,
2003; Yan et al., 2005). However, Sox9 also has many roles in non-
cartilage tissues (Jo et al., 2014), raising the question of how activity
in chondrocytes is specifically regulated. Intriguingly, the
identification of Fox consensus binding motifs as highly enriched
in Sox9-bound enhancers of chondrocyte genes suggests that Fox
proteins might cooperate with Sox9 at chondrocyte enhancers
(Ohba et al., 2015).
Here, we employ the zebrafish system to test the roles of discrete
Fox genes in regulating cartilage, bone and tooth development in the
embryonic face. We find that the distinct expression patterns of
individual Fox genes arise through integration of Hh, Bmp, Fgf, Edn1Received 13 March 2018; Accepted 11 May 2018
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and Notch signaling. Combinatorial mutagenesis reveals requirements
for Fox-C genes in formation of cartilage in the upper face, and for
Fox-F genes in formation of the distal jaws, ventral midline cartilages,
and pharyngeal teeth. These Fox genes appear to be largely
dispensable for dorsoventral patterning, as well as CNC proliferation
and survival. Instead, we find that Fox-C and Fox-F genes are required
for Sox9a to activate effectively a number of known targets in
chondrocytes, including col2a1a, matrilins 1 and 4, and acana.
Rescue experiments also show that Foxc1a is sufficient in CNCs for
facial cartilage formation. Further, CNC-specific misexpression of
either Foxc1a or Foxf1 expands the chondrogenic domain and inhibits
dermal bone formation. We propose that Fox genes function to
integrate diverse signaling outputs to position cartilage and tooth
competency fields precisely in the developing face.
RESULTS
Establishment of distinct arch expression domains of Fox
genes
Examination of our published transcriptome data of arch CNCs
(Askary et al., 2017) revealed the top eight expressed Fox genes to
be foxc1b, foxd1, foxd2, foxc1a, foxf2a, foxl1, foxf1 and foxf2b
[from highest to lowest, all above eight transcripts per million reads
at 36 h post-fertilization (hpf); Fig. S1A]. Fluorescence in situ
hybridization revealed distinct expression domains in arch CNCs
(Fig. 1A). foxc1a, foxc1b and foxd1 were enriched in intermediate
domains of the first and second arches, with strongest expression
around the ventral limit of the first pharyngeal pouch, whereas
foxc1b was expressed in broader domains than foxc1a and foxd1
(Fig. S1D). Although foxd2 showed similar expression at an earlier
stage (30 hpf; Fig. S1B), by 36 hpf it became restricted to CNCs in
the dorsal-posterior regions of the first and second arches. In
contrast, foxf1, foxf2a and foxf2b were expressed in more ventral
regions of the first and second arches, as well as in the maxillary
domain. Expression of foxl1 was observed in the dorsal and ventral
poles of the first two arches. In the more posterior gill-forming
arches, we detected expression of foxf1 in ventral domains at 36 and
48 hpf, foxc1b in intermediate domains at 48 hpf, and foxd2 in
dorsal domains at 48 hpf (Fig. S1C,E). We also observed exclusion
of foxc1a, foxc1b, foxd2 and foxf1 from developing sox9a+
chondrocytes at 48 hpf, with the exception of foxc1a and foxc1b
in some nascent sox9a+ cells in the hyoid joint region (Fig. S1E,F).
Furthermore, foxc1b and foxf1were expressed in distinct domains in
and around the developing neurocranium, a structure analogous to
the mammalian palate, and foxf1 was expressed in tooth-forming
mesenchyme of the fifth branchial arch (Fig. S1G,H). These
patterns are reminiscent of the expression of their mouse orthologs
at embryonic day 10.5, such as the reported ‘first pouch adjacent’
expression of Foxc2, Foxd1 and Foxd2 and the mandibular and
maxillary expression of Foxf1 and Foxf2 (Jeong et al., 2004).
We next interrogated how these distinct expression patterns arise.
As described for Foxc2, Foxd1, Foxd2, Foxf1 and Foxf2 in mouse
(Jeong et al., 2004), we found that upregulation of Hh signaling,
through heat shock-regulated misexpression of Shha starting at
20 hpf, increased expression of foxc1a, foxc1b, foxd1, foxd2 and
foxf1 throughout most of the arches (Fig. 1B, Fig. S2). However,
different effects of manipulating Bmp, Fgf, Edn1 and Jagged-Notch
signaling were observed on individual Fox genes (Fig. 1B,C,
Fig. S2). Misexpression of Bmp4 or Fgf3 reduced foxc1a, foxc1b,
foxd1 and foxd2 yet expanded foxf1 expression. In edn1 mutants,
foxc1a, foxc1b and foxd1 expression was reduced, foxf1 became
diffusely expressed throughout the second arch but reduced in the
first arch, and foxd2 was modestly expanded into more ventral
Fig. 1. Combinatorial signaling establishes distinct Fox expression domains. (A) In situ hybridization at 36 hpf shows expression of Fox genes (green)
relative to dlx2a+ CNCs (red) of the first two arches. (B) Expression of foxc1a, foxd2 and foxf1 (green) relative to dlx2a+ CNCs (red) upon misexpression of Shha,
Bmp4 or Fgf3. Embryos doubly transgenic for hsp70l:Gal4 and UAS:shha, UAS:bmp4 or UAS:fgf3 were subjected to heat shock induction from 20 to 24 hpf
and then fixed at 36 hpf for analysis. (C) Expression of foxc1a, foxd2 and foxf1 (green) relative to dlx2a+ CNCs (red) in edn1 or jag1b mutants versus sibling
controls. Numbers denote proportions of embryos with displayed patterns. Scale bars: 25 μm. (D) Summary of positive and negative inputs on Fox expression in
the first two arches.
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regions. Consistent with similar expression of jag1b and foxd2
(Zuniga et al., 2010), only expression of foxd2 was lost in jag1b
mutants. These results indicate combinatorial regulation of Fox
expression. Shh induces all Fox genes examined; foxc1a, foxc1b
and foxd1 are restricted to intermediate regions by positive Edn1 and
negative Bmp and Fgf signaling; foxd2 becomes restricted to dorsal-
posterior regions by positive Jagged-Notch and negative Bmp and
Fgf signaling; and foxf1 is restricted to distal/ventral regions largely
through positive Bmp and Fgf signaling (Fig. 1D).
Dose-dependent requirements for Fox-C genes in upper
facial cartilage formation
We next used TALEN or CRISPR/Cas9 mutagenesis to create
frame-shift alleles for foxc1a, foxc1b, foxd1, foxd2, foxf1, foxf2a,
foxf2b and foxl2, in addition to obtaining a foxl1 nonsense allele
from the Sanger Center. In all cases, mutations are predicted to
cause protein truncations in or before the conserved Forkhead DNA-
binding domains, thus likely abrogating most, if not all, function
(Fig. S3A). Homozygous mutants for foxc1b, foxd1 and foxd2
displayed no obvious larval craniofacial skeletal defects and
survived past juvenile stages, with only foxd2 mutants exhibiting
a growth delay by 2 months. The larval craniofacial skeleton was
also unaffected in foxd1−/−; foxd2−/− double mutants (Fig. S3B). In
contrast, homozygous foxc1a mutants died by 7 days post-
fertilization (dpf), and displayed facial cartilage defects, as well
as cardiac edema that likely accounts for the overall reduced head
growth (Fig. 2). After normalizing for overall cartilage/head
reduction, we found that mutants had a particularly short
Fig. 2. Loss of upper facial cartilage in Fox-C mutants. (A) Ventral views of dissected facial skeletons, with cartilage in blue and bones and teeth in red.
Schematics show affected elements in color. Ch, ceratohyal; Hm, hyomandibular; M, Meckel’s; Pq, palatoquadrate; Sy, symplectic. (B) Lateral views of intact
heads stained with Alcian Blue (cartilage) and Alizarin Red (bones and teeth). Shown below are unilateral dissections of skeletal elements of the first and
second arches (red boxed region). Accompanying schematics show dose-dependent reductions of the Pq (magenta), Sy (green) and Hm (blue) cartilages.
foxc1a−/− and foxc1a−/−; foxc1b−/− mutants also display cardiac edema and an overall smaller head. (C) Quantification of the relative length of Sy compared
with Ch. ***P<0.001 versus wild-type sibling control using Student’s t-test. n.s., not significant versus control (P=0.35). Error bars represent s.e.m. (D) Dissections
of neurocranial cartilages show loss of the trabecular cartilages (Tr, arrow) in foxc1a−/−; foxc1b−/− mutants. Numbers denote proportions of embryos with
displayed phenotypes. Ep, ethmoid plate. Scale bars: 25 μm.
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symplectic (Sy) cartilage, an element derived from the intermediate
portion of the second arch. Sy reduction was not secondary to
cardiac edema, as foxc1a+/−; foxc1b−/− animals displayed a similar
Sy truncation without cardiac edema, and heterozygosity of foxc1b
enhanced Sy loss in foxc1a−/− animals (Fig. 2A-C). In double
homozygous foxc1a; foxc1b mutants, we observed severe
reductions of upper facial cartilages, including not only the Sy but
also the palatoquadrate (Pq, a dorsal-intermediate first arch
cartilage) and hyomandibula (Hm, a dorsal second arch cartilage).
We also observed missing or reduced trabecular cartilage of the
neurocranium (Fig. 2D). However, the lower jaw Meckel’s (M) and
lower jaw support ceratohyal (Ch) cartilages were relatively
unaffected. Photoconversion of sox10:kikGR+ arch CNCs in a
similar domain to where foxc1a, foxc1b and foxd1 are co-expressed
at 36 hpf resulted in labeling of the Sy, Pq and Hm cartilages by
6 dpf, i.e. those elements most affected in mutants (Fig. S4). Our
results support the hypothesis that Foxc1a and Foxc1b act
redundantly, and possibly cell-autonomously, in upper facial
cartilage development.
Dose-dependent requirement for Fox-F genes in midline
cartilage and pharyngeal tooth formation
We next examined potential roles for Fox-F and Fox-L genes in
facial development. Single mutants for foxf2a, foxf2b, foxl1 and
foxl2, and double mutants for foxf2a; foxf2b and foxl1; foxl2,
displayed no obvious craniofacial defects and survived to
adulthood (Fig. S3B,C). Single foxf1 mutants also had normal
larval facial skeletons yet did not survive past 10 dpf, displaying a
failure of swim bladder inflation and a reduced intestine (Fig. S5),
consistent with roles for Foxf1 in intestinal development in frog
(Tseng et al., 2004) and mouse (Ormestad et al., 2006). In contrast,
foxf1; foxf2a double mutants displayed mild midline cartilage
defects, which were further enhanced by loss of fox2b alleles. In
foxf1; foxf2a double mutants with at least one foxf2b allele
disrupted, we observed distal truncations of the upper jaw
(pterygoid process), lower jaw (M) and lower jaw support (Ch)
cartilages; complete loss of midline cartilages (basihyal and
basibranchials); and absence of pharyngeal teeth. We also
observed absence of the trabecular cartilage of the neurocranium
in foxf1; foxf2a; foxf2b triple mutants (Fig. 3A-C). Histological
analysis revealed a complete absence of tooth buds in triple
mutants, and in situ hybridization revealed losses of the early tooth
markers dlx2b and fgf3 at 56 hpf (Fig. 3D-F).We conclude that Fox-F
genes have dose-dependent requirements for the formation of distal
jaw, midline and neurocranial cartilages, as well as teeth, consistent
with their expression in the distal-most regions of each pharyngeal
arch and the tooth-bearing seventh arch.
Fox genes are largely dispensable for the dorsoventral
patterning, proliferation and survival of arch CNCs
Given the regional cartilage defects of Fox-C and Fox-F mutants,
we examined whether this might reflect earlier defects in the
dorsoventral patterning, growth or survival of CNCs. For example,
Sy defects in Fox-C mutants are similar to those seen upon loss of
the dorsoventrally intermediate Dlx3-6 genes (Talbot et al., 2010),
and the distal jaw truncations of Fox-F mutants are reminiscent of
those seen upon loss of the ventral hand2 gene (Miller et al., 2003).
However, expression of dorsal ( jag1b), intermediate (dlx5a and
msx1a) and ventral (hand2) genes were largely unaffected in Fox-C
and Fox-F mutants, although we did observe a reduction of the
hand2+ ventral first arch domain in Fox-F mutants (Fig. 4A).
Examination of bromodeoxyuridine (BrdU) incorporation (48 hpf)
and terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining (56 hpf) also revealed no significant
differences in proliferation or apoptosis, respectively, in Fox-C and
Fox-F mutants (Fig. 4B-E′). These results indicate that the
cartilage defects of Fox mutants are unlikely to be due to altered
dorsoventral patterning, growth, or survival of CNCs, at least at
the stages examined.
Altered cartilage gene expression downstream of Sox9a in
Fox mutants
We next examined whether Fox genes might control distinct steps in
cartilage differentiation. During normal zebrafish craniofacial
development, barx1 and then sox9a mark CNCs in pre-cartilage
condensations (Nichols et al., 2013; Barske et al., 2016). Sox9a then
induces a number of cartilage differentiation genes, including those
encoding for the extracellular matrix components Type II Collagen
(col2a1a), Aggrecan (acana) and Matrilin (matn1 and matn4). In
foxc1a; foxc1b and foxf1; foxf2a; foxf2b mutants, the initiation of
barx1 and sox9a expression in the developing arches was largely
unaffected (Fig. 5A-C). Reciprocally, foxc1a was expressed
normally in the arches of sox9a mutants (Fig. S6A). However,
expression of the Sox9 target genes col2a1a, matn1 and matn4, and
to a lesser extent acana, was specifically reduced in the nascent
sox9a+ upper facial cartilages affected in foxc1a; foxc1b mutants
(Fig. 5B). The exact nature of col2a1a and matn4 reduction varied
between affected animals. Similarly, expression of col2a1a, matn1,
matn4 and acana was specifically reduced in the nascent sox9a+
ventral midline cartilages affected in foxf1; foxf2a; foxf2b mutants,
as shown for the lower jaw Meckel’s cartilages (Fig. 5C). We
observed a similar upper face-specific loss of a col2a1:mCherry-
NTR transgene in foxc1a; foxc1b mutants; in contrast, expression of
a sp7:EGFP transgene that labels osteoblasts of early-forming
dermal bones was unaffected (Fig. S6B). These data show that
Fox-C and Fox-F factors are required for the expression of Sox9a
target genes, but not sox9a itself, in distinct cartilage-forming
domains of the developing face.
CNC misexpression of Fox genes expands facial cartilage
and reduces dermal bone
At 36 hpf, we found that sox9a is expressed in a broader domain in
the first two arches than foxc1a and foxf1 (Fig. 6A). In particular,
pooling of foxc1a, foxc1b, foxd1 and foxd2 probes revealed dorsal
sox9a+ domains that do not appear to co-express any of the Fox
genes examined (Fig. 6B,F). We therefore examined whether forced
expression of Fox genes could expand cartilage formation into these
sox9a-only domains. To do so, we used a fli1a:Gal4VP16 driver to
misexpress UAS-driven Foxc1a or Foxf1 transgenes throughout
arch CNC mesenchyme. Misexpression of either Foxc1a or Foxf1
resulted in ectopic cartilage processes dorsal to the Pq and posterior
to the Hm, and loss of the opercle, an early-forming dermal bone
(Fig. 6C). Consistent with sox9a expression being unaffected in
Fox-C and Fox-F mutants, we did not observe an expansion of
sox9a expression upon Foxc1a or Foxf1 misexpression. In addition,
loss of dermal bone was reflected by earlier loss of the osteogenic
gene runx2b (Fig. 6D). CNCmisexpression of Foxc1a was also able
to rescue the facial and neurocranial cartilage defects of foxc1a;
foxc1bmutants; however, cardiac edemawas not rescued, consistent
with the heart being derived from mesoderm (Fig. 6E). Thus,
Foxc1a function is sufficient in CNCs for facial cartilage formation.
Our findings are consistent with Fox misexpression expanding the
regions in which Sox9a can induce cartilage, potentially at the
expense of dermal bone (Fig. 6F).
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DISCUSSION
The region-specific cartilage and tooth defects seen in fish lacking
distinct combinations of Fox-C/F genes support the concept of a
Fox code of facial skeletal patterning first proposed by Jeong et al.
(2004). Whereas Edn1 and Jagged-Notch signaling interact to
regulate sox9a expression along the dorsoventral arch axis (Barske
et al., 2016), sox9a expression is not dependent on Fox-C/F genes.
Instead, our work reveals that Fox-C/F factors are locally required
for Sox9a to promote cartilage differentiation. We find that at least
five signaling pathways –Hh, Fgf, Bmp, Edn1 and Jagged-Notch –
interact to establish distinct expression domains of individual Fox
genes. Diverse signaling pathways thus interact to position Fox and
Sox expression domains independently, with the unique overlap of
these two types of transcription factors positioning individual
cartilage elements in the developing face.
Although we observed local reduction or loss of facial cartilage in
Fox-C and Fox-F mutants, other cartilage elements (e.g. ceratohyal)
were largely unaffected in both. Although Foxc1 has been
implicated in cartilage development in the limb and sternum of
mouse (Kume et al., 1998; Yoshida et al., 2015), we also did not
observe any defects in pectoral fin cartilage in fish Fox-C or Fox-F
mutants (Fig. S7). Furthermore, expression of Sox9a target genes,
such as col2a1a and acana, was only partially reduced in Fox-C/F
mutants. One explanation for the partial nature of defects is
additional redundancy with other members of the Fox family.
Indeed, we observed expression of a large number of Fox genes in
the developing face, and our analysis of Fox-C and Fox-F genes
revealed widespread functional redundancy. It may also be that Fox
factors function to ensure maximal activation of Sox9 target genes,
with Sox9 able to drive some level of cartilage gene expression even
in the absence of Fox genes. Finally, particular cartilages may have a
larger dependence on Fox genes for their differentiation.
The finding of upper facial cartilage defects in Fox-C zebrafish
mutants, and repression of dermal bone by Foxc1a misexpression, is
consistent with reported roles of Fox-C genes in mice. Foxc2mutant
mice display reductions of the pterygoquadrate cartilage and fusion
Fig. 3. Loss of midline cartilage and pharyngeal teeth in Fox-F mutants. (A) Ventral views of dissected facial skeletons, with cartilage in blue and bones
and teeth in red. Schematics show affected elements in color. Bb, basibranchials; Bh, basihyal; Ch, ceratohyal; M, Meckel’s; Ptp, pterygoid process. (B) Lateral
views of wild-type sibling control and foxf1; foxf2a; foxf2b triple mutant at 5 dpf. Mutants show anterior truncation of the head (arrow). (C) Dissections of
neurocranial cartilages show loss of the trabecular cartilages (Tr, arrow) in foxf1; foxf2a; foxf2b triple mutants. Ep, ethmoid plate. (D) Sagittal sections through the
tooth-forming seventh arch of a wild-type sibling control and foxf1; foxf2a; foxf2b triple mutant at 4 dpf. All teeth (3V1, 4V2 and 5V1) are missing in mutants.
c, chorda; cb5, ceratobranchial 5; ov, otic vesicle. (E,F) Whole-mount in situ hybridizations show loss of dlx2b (E) and fgf3 (F) in the developing tooth regions
(arrows) of foxf1; foxf2a; foxf2b triple mutants. Numbers denote proportions of embryos with displayed phenotypes or expression patterns. Scale bars: 25 μm.
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of the malleus and incus cartilages (Iida et al., 1997), with these
elements deriving from similar upper/dorsal regions of the
mandibular arch as in fish. Foxc1 also has a role in repressing
bone differentiation in mice. Foxc1 mutant mice display increased
dermal bone that fuses the jaws (Hong et al., 1999; Kume et al.,
2001; Inman et al., 2013) and precocious differentiation of
calvarial osteoblasts, ultimately leading to reduced skull bones
(Hong et al., 1999; Sun et al., 2013). However, although we
observed repression of bone development by Foxc1a or Foxf1
misexpression in zebrafish, we failed to observe ectopic bone in
any of the Fox mutant combinations analyzed. The neurocranial
cartilage defects of Fox-C and Fox-F mutants are also potentially
analogous to the cleft palate seen in Foxc2, Foxf1 and Foxf2
mouse mutants (Iida et al., 1997; Wang et al., 2003; Xu et al.,
2016). In addition, tooth loss in zebrafish Fox-F mutants is
consistent with expression of Foxf1 in the developing tooth
mesenchyme of mice (Wang et al., 2003). It was difficult to assess
whether tooth reduction in zebrafish Fox-C mutants was an
indirect consequence of severe cardiac edema, but loss of FOXC1
in Axenfeld–Rieger Syndrome is associated with missing and
reduced teeth (Tümer and Bach-Holm, 2009). These extensive
similarities highlight conserved functions of Fox-C/F genes
between fish and mammals and reveal a functional role for
Fox-F genes in tooth formation.
The mechanisms by which Sox and Fox proteins interact to
regulate chondrogenesis remain unclear. Sox9 is known to directly
bind the enhancers of a number of cartilage genes, includingCol2a1
and Acan (Lefebvre et al., 1997; Ohba et al., 2015; Yasuda et al.,
2017). The observation that consensus Fox binding sites are highly
enriched in the vicinity of Sox9-bound enhancers in chondrocytes
(Ohba et al., 2015) suggests that Fox and Sox factors may bind to
some of the same enhancers. The finding that Foxc1a and Sox9a do
not regulate the expression of each other further suggests that Fox
and Sox proteins act in parallel to regulate chondrocyte enhancers.
One possibility is that a subset of enhancers for chondrocyte genes is
co-bound by Fox-C/F and Sox9 to promote transcription. An
intriguing, alternative possibility is that Fox-C/F may bind
chondrocyte enhancers first, thus preparing them for later Sox9
binding and activation. Consistent with this, we find that Fox-C/F
expression in the arches generally precedes sox9a expression, and
then shuts off during early chondrocyte differentiation. Although it
is known that FoxA factors and Foxd3 can bind enhancers in a
closed chromatin conformation and displace nucleosomes to allow
later gene activation (Cirillo and Zaret, 1999; Xu et al., 2009), it
remains to be determined whether Fox-C/F factors might act
similarly in chondrocyte precursors. Future studies that assess
chromatin status in the presence or absence of Fox-C/F factors will
be required to test directly how Fox and Sox factors act together to
promote cartilage formation.
MATERIALS AND METHODS
Zebrafish transgenic lines and mutants
The Institutional Animal Care and Use Committee of the University of
Southern California approved all animal experiments performed in this
study (Protocol #10885). We staged zebrafish (Danio rerio) as described
(Kimmel et al., 1995). Published lines include edn1tf216b (Miller et al.,
2000), jag1bb1105 (Zuniga et al., 2011), sox9atw37 (Yan et al., 2005),
Tg(UAS:bmp4;cmlc2:GFP)el49 (Zuniga et al., 2011), Tg(sp7:EGFP)b1212
Fig. 4. Dorsoventral gene expression, proliferation and apoptosis in Fox mutants. (A) Fluorescence in situ hybridizations of the first two arches (numbered)
show expression of jag1b (dorsal), msx1a and dlx5a (intermediate), or hand2 (ventral) in green relative to dlx2a+ arch CNCs in red. Expression is largely
unaffected in foxc1a; foxc1b double mutants (c1a−/−; c1b−/−) and foxf1; foxf2a; foxf2b triple mutants ( f1−/−; f2a−/−; f2b−/−) compared with sibling controls, with the
exception of reduced hand2 in the ventral first arch of foxf1; foxf2a; foxf2b triple mutants (arrows). (B-C′) Analysis of proliferation. Confocal sections show BrdU+
cells (red) compared with all nuclei (Hoechst, blue) in lateral views of the first two arches (numbered) of foxc1a−/−; foxc1b−/− embryos and ventral views of the first
arch Meckel’s cartilage domains (M) of foxf1−/−; foxf2a−/−; foxf2b−/− embryos, relative to sibling controls. Dashed lines represent the regions quantified in the
accompanying graphs. (D-E′) Analysis of apoptosis. Maximum intensity projections show the number of TUNEL+ cells (green) in lateral views of the first two
arches (numbered) of foxc1a−/−; foxc1b−/− embryos and ventral views of the first arch M cartilage domains of foxf1−/−; foxf2a−/−; foxf2b−/− embryos, relative to
sibling controls. Dashed lines represent the regions quantified in the accompanying graphs. Error bars represent s.e.m. Scale bars: 50 μm. n.s., not significant.
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(DeLaurier et al., 2010), Tg(hsp70I:Gal4)kca4 (Scheer and Campos-Ortega,
1999), Tg(sox10:kikGR)el2 and Tg(UAS:shha;cmlc2:GFP)el137 (Balczerski
et al., 2012), Tg(col2a1aBAC:mCherry-NTR)el559 and Tg(sox10:
GFPCAAX)el375 (Askary et al., 2015). The Gateway (Invitrogen) Tol2Kit
(Kwan et al., 2007) was used to generate fli1a:Gal4VP16, UAS:fgf3, UAS:
foxc1a andUAS:foxf1. fli1a:Gal4VP16was created by combining p5E-fli1a
(Das and Crump, 2012), pME-Gal4VP16, p3E-pA and pDestTol2CG2.
Three independent lines were isolated, and the stable line Tg(fli1a:
Gal4VP16;cmlc2:GFP)el360 was used for this study. For UAS:fgf3, UAS:
foxc1a and UAS:foxf1, the coding sequences of fgf3, foxc1a and foxf1 were
amplified using the primers listed in Table S3 and cloned into pDONR221
to generate pME-fgf3, pME-foxc1a and pME-foxf1, followed by LR cloning
with p5E-UAS, p3E-pA, and pDestTol2CG2 or pDestTol2AB2. Two
independent transgenic lines were isolated for Tg(UAS:fgf3;cmlc2:GFP),
Tg(UAS:foxc1a;α-crystallin:Cerulean) and Tg(UAS:foxf1;α-crystallin:
Cerulean). We used the stable lines Tg(UAS:fgf3;cmlc2:GFP)el688,
Tg(UAS:foxc1a;α-crystallin:Cerulean)el700 and Tg(UAS:foxf1;α-crystallin:
Cerulean)el751 for this study. foxl1sa1842 was provided by the Sanger center.
TALEN mutagenesis (Sanjana et al., 2012) was used to create four alleles:
foxc1ael542, foxc1ael543, foxd1el551 and foxd2el575. CRISPR/Cas9
mutagenesis (Jao et al., 2012) was used to create six alleles: foxc1bel620,
foxf1el658, foxf1el660, foxf2ael616, foxf2bel621 and foxl2el615. Given that
foxc1ael542 and foxf1el658; foxf2ael616; foxf2bel621 mutant embryos showed
identical defects to foxc1ael543 and foxf1el660; foxf2ael616; foxf2bel621,
respectively, we used foxc1ael542 and foxf1el658 for this study. See Fig. S3 for
description of mutations, and Table S1 for a list of TALEN and CRISPR
constructs and genotyping details. For hsp70l:Gal4 experiments, embryos
were placed in a 40°C incubator from 20-24 hpf and then transferred to
28.5°C, with hsp70l:Gal4-negative siblings serving as controls. All
phenotypes were scored blinded to genotype.
Skeletal staining and histology
Acid-free Alcian Blue and Alizarin Red staining of cartilage and bone was
performed on 5-6 dpf larvae as described (Walker and Kimmel, 2007).
Whole-mount and dissected skeletons were imaged with Leica S8APO and
DM2500 microscopes, respectively. For sectioning and histology, embryos
were fixed in 1.5% parafomaldehyde, 1.5% glutaraldehyde, 0.1 M sodium
cacodylate (pH 7.4), 0.001% CaCl2, embedded in epon, and 1-μm-thick
Fig. 5. Fox genes are required for chondrogenic gene
expression downstreamof Sox9a. (A) Fluorescence in situ
hybridizations show that barx1+ pre-cartilage condensations
of the first two arches are unaltered in foxc1a; foxc1b double
mutants (c1a−/−; c1b−/−) and foxf1; foxf2a; foxf2b triple
mutants ( f1−/−; f2a−/−; f2b−/−) compared with sibling
controls. (B,C) Schematic of the cartilaginous facial skeleton
shows regions examined by fluorescence in situ
hybridization. Maximum intensity projections for foxc1a;
foxc1b mutants at 56 hpf (B) and representative sections for
foxf1; foxf2a; foxf2b mutants at 72 hpf (C) show expression
of the chondrogenic genes col2a1a, matn1, matn4 or acana
(green) relative to sox9a (red). Arrows indicate regions in
which sox9a+ cells have reduced chondrogenic gene
expression relative to sibling controls. Numbers denote
proportions of embryos with displayed patterns.
Scale bars: 50 μm.
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serial sections were obtained. Sections were stained with Toluidine Blue and
observed with a Zeiss Axio Imager ZZ microscope equipped with a digital
Zeiss AxioCam ICc3 camera.
In situ hybridization and immunohistochemistry
Published in situ probes include dlx2a (Akimenko et al., 1994), dlx5a
(Walker et al., 2006), fgf3 (Choe and Crump, 2014), jag1b (Zuniga et al.,
2010), hand2 (Angelo et al., 2000), msx1a (Akimenko et al., 1995), sox9a
(Yan et al., 2002), runx2b (Paul et al., 2016), barx1 (Barske et al., 2016),
col2a1a and acana (Askary et al., 2015), matn1 (Askary et al., 2016), and
foxd1, foxf1 and foxf2a (Askary et al., 2017). Partial cDNAs for foxc1a,
foxc1b, foxd2, foxf2b, foxl1, dlx2b and matn4 were PCR amplified with Q5
High-Fidelity DNA Polymerase (New England Biolabs) and cloned into
pCR Blunt II Topo (Thermo Fisher Scientific). Sequence-verified plasmids
were linearized, and antisense probes were synthesized with Sp6 or T7
RNA polymerase (Roche Life Sciences) using dioxygenin (DIG)- or
dinitrophenol (DNP)-labeled nucleotides (Roche). See Table S2 for probe
generation details. Fluorescence and colorimetric in situ hybridizations were
performed as described (Zuniga et al., 2010). For in situ hybridization on a
sox10:GFPCAAX background, after the in situ protocol we added primary
antibody rabbit anti-GFP (1:200; Torrey Pines Biolabs, TP401) diluted in
PBDTx (PBS with 1% bovine serum albumin, 1% DMSO, 0.1% Triton X-
100), incubated overnight at 4°C, washed four times with PBDTx, added
secondary antibody goat anti-rabbit (1:500; Invitrogen A11008), incubated
overnight at 4°C, and washed several times with PBDTx. We used a Zeiss
LSM800 confocal microscope to capture fluorescence images, with
representative sections or maximum intensity projections shown as
specified. Colorimetric images were obtained on a Leica S8APO
microscope. Levels were modified consistently across samples in Adobe
Photoshop CS6.
Proliferation and apoptosis assays
BrdU incorporation was performed as described (Laguerre et al., 2005).
Briefly, live embryos were manually removed from their chorions at 46 hpf,
incubated in 15 mM BrdU (Sigma-Aldrich) in 15% DMSO for 25 min at
28.5°C, harvested at 48 hpf, and fixed with 4% paraformaldehyde
Fig. 6. Fox CNC misexpression induces ectopic cartilage and inhibits dermal bone. (A) Confocal sections show expression of foxc1a or foxf1 (green)
relative to sox9a (red) in sox10:GFPCAAX+ CNCs of the first two arches (anti-GFP, blue). (B) Maximum intensity projection shows fluorescence in situ
hybridization using pooled probes against foxc1a, foxc1b, foxd1 and foxd2 (green) relative to sox9a (red). (C) Unilateral dissections of the first and second
arch skeletons stained for cartilage (Alcian Blue) and bone (Alizarin Red). CNC misexpression of Foxc1a ( fli1a:Gal4VP16; UAS:foxc1a) or Foxf1
( fli1a:Gal4VP16; UAS:foxf1) results in ectopic cartilage in the upper face (arrowheads), and loss of the opercle bone (arrows). (D) Double fluorescence in situ
hybridizations of the first two arches show reduction of the osteoblast gene runx2b (red) in the future opercle bone (arrow) but no change in sox9a (green)
upon misexpression of Foxc1a or Foxf1. (E) Dissections of the first and second arch skeletons and neurocranial cartilages. Misexpression of Foxc1a in CNCs
( fli1a:Gal4VP16; UAS:foxc1a) rescues cartilage development in the upper face (top) and neurocranium (bottom). Scale bars: 50 μm. (F) Model of how arch-wide
Fox misexpression expands the territory in which Sox9a induces cartilage (blue) at the expense of dermal bone (red).
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overnight. Fixed embryos were washed three times with PBST (PBS with
0.25% Tween-20) and twice with deionized water. Embryos were incubated
in 2 N HCl for 1 h at room temperature, washed three times with PBST, and
incubated in block solution (2% normal goat serum, 0.1% bovine serum
albumin, 1% DMSO in PBST) for at least 2 h. Embryos were then incubated
with primary antibody rat anti-BrdU (1:200; Bio-Rad, MCA2060GA)
overnight at 4°C, followed by secondary antibody goat anti-rat Alexa Fluor
568 (1:500; Invitrogen, A11077) and Hoechst to visualize nuclei. The ratio
of BrdU-positive to total cells in the specified regions were calculated. For
apoptosis, we performed TUNEL staining using the ApopTag Fluorescein
In Situ Apoptosis Detection Kit (Millipore, S7110). Briefly, fixed embryos
were washed twice with PBST, transferred to Equilibration Buffer for 3 min
at room temperature, and incubated in the working strength TdT enzyme for
2 h at 37°C. The reaction was stopped in working strength stop/wash buffer
for 10 min at room temperature, and then embryos were incubated with anti-
DIG antibody overnight at 4°C, together with Hoechst to visualize nuclei.
TUNEL-positive cells were calculated in the intermediate and dorsal regions
of first and second arches for foxc1a; foxc1b double mutants and the ventral
midline area of the first arch for foxf1; foxf2a; foxf2b triple mutants.
Measurement of relative length of symplectic and ceratohyal
cartilages
Cartilage lengths were measured using ImageJ software. The relative lengths
of Sy to Ch were compared between control and the indicated mutant
genotypes using a Student’s t-test (two-tailed, type 3), with P<0.001
considered significant.
Analysis of cell death and proliferation
The numbers of apoptotic (TUNEL+) and proliferating (BrdU+) cells in the
first two arches were compared between control and Fox-C or Fox-F mutant
embryos using the Student’s t-test (two-tailed, type 3), with P>0.1
considered non-significant.
Acknowledgements
We are indebted to Megan Matsutani and Jennifer DeKoeyer Crump for fish care.
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: P.X., B.B., J.G.C.; Methodology: P.X., B.B., J.G.C.; Formal
analysis: P.X., B.B., J.G.C.; Investigation: P.X., B.B., A.C., K.L., V.O.; Writing -
original draft: P.X., J.G.C.; Writing - review & editing: P.X., J.G.C.; Supervision: A.H.,
J.G.C.; Project administration: J.G.C.; Funding acquisition: J.G.C.
Funding
This work was funded by the National Institute of Dental and Craniofacial
Research (R01-DE018405 and R35-DE027550 to J.G.C.). Deposited in PMC for
release after 12 months.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.165498.supplemental
References
Akimenko, M. A., Ekker, M., Wegner, J., Lin, W. and Westerfield, M. (1994).
Combinatorial expression of three zebrafish genes related to distal-less: part of a
homeobox gene code for the head. J. Neurosci. 14, 3475-3486.
Akimenko, M. A., Johnson, S. L., Westerfield, M. and Ekker, M. (1995).
Differential induction of four msx homeobox genes during fin development and
regeneration in zebrafish. Development 121, 347-357.
Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. and de Crombrugghe,
B. (2002). The transcription factor Sox9 has essential roles in successive steps of
the chondrocyte differentiation pathway and is required for expression of Sox5 and
Sox6. Genes Dev. 16, 2813-2828.
Alexander, C., Zuniga, E., Blitz, I. L., Wada, N., Le Pabic, P., Javidan, Y., Zhang,
T., Cho, K. W., Crump, J. G. and Schilling, T. F. (2011). Combinatorial roles for
BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the craniofacial
skeleton. Development 138, 5135-5146.
Angelo, S., Lohr, J., Lee, K. H., Ticho, B. S., Breitbart, R. E., Hill, S., Yost, H. J.
and Srivastava, D. (2000). Conservation of sequence and expression of
Xenopus and zebrafish dHAND during cardiac, branchial arch and lateral
mesoderm development. Mech. Dev. 95, 231-237.
Askary, A., Mork, L., Paul, S., He, X., Izuhara, A. K., Gopalakrishnan, S., Ichida,
J. K., McMahon, A. P., Dabizljevic, S., Dale, R. et al. (2015). Iroquois proteins
promote skeletal joint formation by maintaining chondrocytes in an immature
state. Dev. Cell 35, 358-365.
Askary, A., Smeeton, J., Paul, S., Schindler, S., Braasch, I., Ellis, N. A.,
Postlethwait, J., Miller, C. T. and Crump, J. G. (2016). Ancient origin of
lubricated joints in bony vertebrates. Elife 5, e16415.
Askary, A., Xu, P., Barske, L., Bay, M., Bump, P., Balczerski, B., Bonaguidi,
M. A. and Crump, J. G. (2017). Genome-wide analysis of facial skeletal
regionalization in zebrafish. Development 144, 2994-3005.
Balczerski, B., Matsutani, M., Castillo, P., Osborne, N., Stainier, D. Y. and
Crump, J. G. (2012). Analysis of sphingosine-1-phosphate signaling mutants
reveals endodermal requirements for the growth but not dorsoventral patterning of
jaw skeletal precursors. Dev. Biol. 362, 230-241.
Barske, L., Askary, A., Zuniga, E., Balczerski, B., Bump, P., Nichols, J. T. and
Crump, J. G. (2016). Competition between jagged-notch and endothelin1
signaling selectively restricts cartilage formation in the zebrafish upper face.
PLoS Genet. 12, e1005967.
Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B. (1999).
Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89.
Choe, C. P. and Crump, J. G. (2014). Tbx1 controls the morphogenesis of
pharyngeal pouch epithelia through mesodermal Wnt11r and Fgf8a.
Development 141, 3583-3593.
Cirillo, L. A. and Zaret, K. S. (1999). An early developmental transcription factor
complex that is more stable on nucleosome core particles than on free DNA.Mol.
Cell 4, 961-969.
Das, A. and Crump, J. G. (2012). Bmps and id2a act upstream of Twist1 to restrict
ectomesenchyme potential of the cranial neural crest. PLoS Genet. 8, e1002710.
DeLaurier, A., Eames, B. F., Blanco-Sánchez, B., Peng, G., He, X., Swartz, M. E.,
Ullmann, B., Westerfield, M. and Kimmel, C. B. (2010). Zebrafish sp7:EGFP: a
transgenic for studying otic vesicle formation, skeletogenesis, and bone
regeneration. Genesis 48, 505-511.
Fang, J., Dagenais, S. L., Erickson, R. P., Arlt, M. F., Glynn, M. W., Gorski, J. L.,
Seaver, L. H. and Glover, T. W. (2000). Mutations in FOXC2 (MFH-1), a forkhead
family transcription factor, are responsible for the hereditary lymphedema-
distichiasis syndrome. Am. J. Hum. Genet. 67, 1382-1388.
Hong, H.-K., Lass, J. H. and Chakravarti, A. (1999). Pleiotropic skeletal and ocular
phenotypes of the mouse mutation congenital hydrocephalus (ch/Mf1) arise from
a winged helix/forkhead transcriptionfactor gene. Hum. Mol. Genet. 8, 625-637.
Iida, K., Koseki, H., Kakinuma, H., Kato, N., Mizutani-Koseki, Y., Ohuchi, H.,
Yoshioka, H., Noji, S., Kawamura, K., Kataoka, Y. et al. (1997). Essential roles
of the winged helix transcription factor MFH-1 in aortic arch patterning and
skeletogenesis. Development 124, 4627-4638.
Inman, K. E., Purcell, P., Kume, T. and Trainor, P. A. (2013). Interaction between
Foxc1 and Fgf8 during mammalian jaw patterning and in the pathogenesis of
syngnathia. PLoS Genet. 9, e1003949.
Jao, L.-E., Appel, B. and Wente, S. R. (2012). A zebrafish model of lethal
congenital contracture syndrome 1 reveals Gle1 function in spinal neural
precursor survival and motor axon arborization. Development 139, 1316-1326.
Jeong, J., Mao, J., Tenzen, T., Kottmann, A. H. and McMahon, A. P. (2004).
Hedgehog signaling in the neural crest cells regulates the patterning and growth of
facial primordia. Genes Dev. 18, 937-951.
Jo, A., Denduluri, S., Zhang, B., Wang, Z., Yin, L., Yan, Z., Kang, R., Shi, L. L.,
Mok, J., Lee, M. J. et al. (2014). The versatile functions of Sox9 in development,
stem cells, and human diseases. Genes Dis. 1, 149-161.
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F.
(1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203,
253-310.
Kume, T., Deng, K.-Y., Winfrey, V., Gould, D. B., Walter, M. A. and Hogan, B. L.
(1998). The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse
mutation congenital hydrocephalus. Cell 93, 985-996.
Kume, T., Jiang, H., Topczewska, J. M. and Hogan, B. L. (2001). The murine
winged helix transcription factors, Foxc1 and Foxc2, are both required for
cardiovascular development and somitogenesis. Genes Dev. 15, 2470-2482.
Kwan, K. M., Fujimoto, E., Grabher, C., Mangum, B. D., Hardy, M. E., Campbell,
D. S., Parant, J. M., Yost, H. J., Kanki, J. P. and Chien, C. B. (2007). The Tol2kit:
a multisite gateway-based construction kit for Tol2 transposon transgenesis
constructs. Dev. Dyn. 236, 3088-3099.
Laguerre, L., Soubiran, F., Ghysen, A., König, N. and Dambly-Chaudier̀e, C.
(2005). Cell proliferation in the developing lateral line system of zebrafish embryos.
Dev. Dyn. 233, 466-472.
Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N. and de Crombrugghe,
B. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the
pro alpha1(II) collagen gene. Mol. Cell. Biol. 17, 2336-2346.
Mears, A. J., Jordan, T., Mirzayans, F., Dubois, S., Kume, T., Parlee, M., Ritch,
R., Koop, B., Kuo, W. L., Collins, C. et al. (1998). Mutations of the forkhead/
winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.
Am. J. Hum. Genet. 63, 1316-1328.
9
RESEARCH ARTICLE Development (2018) 145, dev165498. doi:10.1242/dev.165498
D
E
V
E
LO
P
M
E
N
T
Medeiros, D. M. and Crump, J. G. (2012). New perspectives on pharyngeal
dorsoventral patterning in development and evolution of the vertebrate jaw. Dev.
Biol. 371, 121-135.
Miller, C. T., Schilling, T. F., Lee, K., Parker, J. and Kimmel, C. B. (2000). sucker
encodes a zebrafish Endothelin-1 required for ventral pharyngeal arch
development. Development 127, 3815-3828.
Miller, C. T., Yelon, D., Stainier, D. Y. and Kimmel, C. B. (2003). Two endothelin 1
effectors, hand2 and bapx1, pattern ventral pharyngeal cartilage and the jaw joint.
Development 130, 1353-1365.
Mori-Akiyama, Y., Akiyama, H., Rowitch, D. H. and de Crombrugghe, B. (2003).
Sox9 is required for determination of the chondrogenic cell lineage in the cranial
neural crest. Proc. Natl. Acad. Sci. USA 100, 9360-9365.
Nichols, J. T., Pan, L., Moens, C. B. and Kimmel, C. B. (2013). barx1 represses
joints and promotes cartilage in the craniofacial skeleton. Development 140,
2765-2775.
Ohba, S., He, X., Hojo, H. and McMahon, A. P. (2015). Distinct transcriptional
programs underlie Sox9 regulation of the mammalian chondrocyte. Cell Rep. 12,
229-243.
Ormestad, M., Astorga, J., Landgren, H., Wang, T., Johansson, B. R., Miura, N.
and Carlsson, P. (2006). Foxf1 and Foxf2 control murine gut development by
limiting mesenchymal Wnt signaling and promoting extracellular matrix
production. Development 133, 833-843.
Paul, S., Schindler, S., Giovannone, D., de Millo Terrazzani, A., Mariani, F. V.
and Crump, J. G. (2016). Ihha induces hybrid cartilage-bone cells during
zebrafish jawbone regeneration. Development 143, 2066-2076.
Sanjana, N. E., Cong, L., Zhou, Y., Cunniff, M. M., Feng, G. and Zhang, F. (2012).
A transcription activator-like effector toolbox for genome engineering.Nat. Protoc.
7, 171-192.
Scheer, N. and Campos-Ortega, J. A. (1999). Use of the Gal4-UAS technique for
targeted gene expression in the zebrafish. Mech. Dev. 80, 153-158.
Sun, J., Ishii, M., Ting, M.-C. and Maxson, R. (2013). Foxc1 controls the growth of
the murine frontal bone rudiment by direct regulation of a Bmp response threshold
of Msx2. Development 140, 1034-1044.
Talbot, J. C., Johnson, S. L. and Kimmel, C. B. (2010). hand2 and Dlx genes
specify dorsal, intermediate and ventral domains within zebrafish pharyngeal
arches. Development 137, 2507-2517.
Tseng, H.-T., Shah, R. and Jamrich, M. (2004). Function and regulation of FoxF1
during Xenopus gut development. Development 131, 3637-3647.
Tümer, Z. and Bach-Holm, D. (2009). Axenfeld-Rieger syndrome and spectrum of
PITX2 and FOXC1 mutations. Eur. J. Hum. Genet. 17, 1527-1539.
Walker, M. B. and Kimmel, C. B. (2007). A two-color acid-free cartilage and bone
stain for zebrafish larvae. Biotech. Histochem. 82, 23-28.
Walker, M. B., Miller, C. T., Coffin Talbot, J., Stock, D. W. and Kimmel, C. B.
(2006). Zebrafish furin mutants reveal intricacies in regulating Endothelin1
signaling in craniofacial patterning. Dev. Biol. 295, 194-205.
Wang, T., Tamakoshi, T., Uezato, T., Shu, F., Kanzaki-Kato, N., Fu, Y., Koseki, H.,
Yoshida, N., Sugiyama, T. and Miura, N. (2003). Forkhead transcription factor
Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.
Dev. Biol. 259, 83-94.
Xu, J., Watts, J. A., Pope, S. D., Gadue, P., Kamps, M., Plath, K., Zaret, K. S. and
Smale, S. T. (2009). Transcriptional competence and the active marking of tissue-
specific enhancers by defined transcription factors in embryonic and induced
pluripotent stem cells. Genes Dev. 23, 2824-2838.
Xu, J., Liu, H., Lan, Y., Aronow, B. J., Kalinichenko, V. V. and Jiang, R. (2016). A
Shh-Foxf-Fgf18-Shh molecular circuit regulating palate development. PLoS
Genet. 12, e1005769.
Yamagishi, H., Maeda, J., Hu, T., McAnally, J., Conway, S. J., Kume, T., Meyers,
E. N., Yamagishi, C. and Srivastava, D. (2003). Tbx1 is regulated by tissue-
specific forkhead proteins through a common Sonic hedgehog-responsive
enhancer. Genes Dev. 17, 269-281.
Yan, Y. L., Miller, C. T., Nissen, R. M., Singer, A., Liu, D., Kirn, A., Draper, B.,
Willoughby, J., Morcos, P. A., Amsterdam, A. et al. (2002). A zebrafish sox9
gene required for cartilage morphogenesis. Development 129, 5065-5079.
Yan, Y. L., Willoughby, J., Liu, D., Crump, J. G., Wilson, C., Miller, C. T., Singer,
A., Kimmel, C., Westerfield, M. and Postlethwait, J. H. (2005). A pair of Sox:
distinct and overlapping functions of zebrafish sox9 co-orthologs in craniofacial
and pectoral fin development. Development 132, 1069-1083.
Yasuda, H., Oh, C. D., Chen, D., de Crombrugghe, B. and Kim, J. H. (2017). A
novel regulatorymechanism of type II collagen expression via a SOX9-dependent
enhancer in intron 6. J. Biol. Chem. 292, 528-538.
Yoshida, M., Hata, K., Takashima, R., Ono, K., Nakamura, E., Takahata, Y.,
Murakami, T., Iseki, S., Takano-Yamamoto, T., Nishimura, R. et al. (2015). The
transcription factor Foxc1 is necessary for Ihh-Gli2-regulated endochondral
ossification. Nat. Commun. 6, 6653.
Zuniga, E., Stellabotte, F. and Crump, J. G. (2010). Jagged-Notch signaling
ensures dorsal skeletal identity in the vertebrate face. Development 137,
1843-1852.
Zuniga, E., Rippen, M., Alexander, C., Schilling, T. F. and Crump, J. G. (2011).
Gremlin 2 regulates distinct roles of BMP and Endothelin 1 signaling in
dorsoventral patterning of the facial skeleton. Development 138, 5147-5156.
10
RESEARCH ARTICLE Development (2018) 145, dev165498. doi:10.1242/dev.165498
D
E
V
E
LO
P
M
E
N
T
 
Figure S1. Arch expression of Fox genes 
(A) Transcripts Per Million Reads (TPM) values for Fox genes in FACS-purified arch CNCs at 20, 28, 
and 36 hpf.  
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(B) Fluorescent in situ hybridizations at 30 hpf show similar expression of foxc1a, foxc1b, foxd1, and 
foxd2 (green) in dlx2a+ CNCs (red) of the first two arches.  
 
(C) Fluorescent in situ hybridizations at 36 hpf show expression of foxf1 in the ventral domains 
(arrows) of the gill-bearing branchial arches (numbered 3-6), but only minimal expression of foxc1a 
and foxd2.  
 
(D) Double fluorescent in situ hybridizations at 36 hpf show relative expression of foxc1a (green) to 
foxc1b (red) and foxd1 (red), and foxf1 (red) to foxf2a (green), in Sox10:GFPCAAX+ CNCs (white) of 
the first two arches (dotted lines). foxc1b is more broadly expressed than foxc1a and foxd1.  foxf1 and 
foxf2a are expressed in largely similar domains. 
 
(E-F) Fluorescent in situ hybridizations show expression of foxc1a, foxc1b, foxd2, and foxf1 (green) 
relative to sox9a+ chondrocytes (red) at 48 hpf. By this stage, Fox gene expression is generally 
excluded from early cartilage, including around the distal tip of Meckel’s (M), although expression of 
foxc1a and foxc1b is observed in nascent sox9a+ chondrocytes of the hyoid joint (Hj, arrows). We also 
observe expression of foxc1b and foxd2 in intermediate and dorsal domains (arrows), respectively, of 
the posterior arches, and weak expression of foxc1a in the seventh arch (arrow).  
 
(G) In the developing neurocranium, foxc1b co-localizes with sox9a, while foxf1 is seen in cells 
surrounding the trabeculae (Tr) and ethmoid plate (Ep).  
 
(H) Confocal section shows expression of foxf1 (green) in the dental mesenchyme adjacent to the 
dlx2b+ dental epithelium (red) and the sox10:GFPCAAX+ ceratobranchial cartilage 5 (cb5, labeled in 
white by anti-GFP antibody). Scale bars = 25 μm. 
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Figure S2. Regulation of foxc1b and foxd1 arch expression 
Expression of foxc1b (A) and foxd1 (B) in green, relative to dlx2a+ CNCs (red) of the first two arches. 
Similar to foxc1a in Figure 1, foxc1b and foxd1 expression is expanded by Shha misexpression, 
inhibited by Bmp4 and Fgf3 misexpression, and reduced in edn1 but not jag1b mutants.  Embryos 
doubly transgenic for hsp70l:Gal4 and UAS:shha, UAS:bmp4, or UAS:fgf3 were subjected to a heat-
shock from 20-24 hpf to induce ligand expression throughout embryos. Numbers indicate proportion 
of animals showing the displayed patterns. Scale bars = 25 μm. 
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Figure S3. Fox mutant alleles 
(A) Schematics of Fox alleles generated for this study. The predicted protein products are shown in 
black with the Forkhead DNA-binding domains in magenta. For the targeted DNA sequences, series 
of red dashes indicate deletions, and green letters indicate insertions. For the foxl1sa1842 generated by 
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the Sanger Center, the nonsense mutation (t > a) is indicated in green. Sites where the predicted 
proteins are truncated by mutations are indicated with arrows.  
 
(B-C) Unilateral dissections of the skeletons of the first two arches stained with Alcian Blue (cartilage) 
and Alizarin Red (bone) at 5 dpf (B) or 6 dpf (D). No defects were seen in at least 20 larvae examined 
for each genotype. Scale bars = 25 μm. 
 
 
 
Figure S4. Fate mapping of the Fox-C expression domain 
Images show the first two arches at 36 hpf (A) and the resultant skeleton at 6 dpf (B). sox10:kikGR+ 
arch CNCs (green) were photoconverted to red fluorescence with UV light using the ROI function on 
a Zeiss LSM800 confocal microscope. Photoconversion in a similar domain to where foxc1a and 
foxd1 are expressed resulted in labeling of the palatoquadrate (Pq), symplectic (Sy), and 
hyosymplectic (Hm) cartilages. Scale bars = 25 μm. 
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Figure S5. Phenotype of foxf1 single mutants 
(A) Brightfield images show morphology of control and foxf1 single mutants in lateral view at 6 dpf. 
Swim bladders do not properly inflate in all foxf1 mutants.  
 
(B) Enlarged images of the boxed regions show reduced intestine (dotted areas) in foxf1 mutants 
compared to controls.  
 
(C) Ventral views of dissected facial skeletons stained by Alcian Blue (cartilage) and Alizarin Red 
(bones and teeth). No defects are observeded in foxf1 mutants. Scale bars = 100 μm. 
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Figure S6. Expression of foxc1a in sox9a mutants and chondrocyte defects in Fox-C mutants 
(A) Expression of foxc1a in the first two arches is unchanged in sox9a mutants at 42hpf.  	
(B) Confocal imaging of chondrocytes labeled by col2a1:mCherry-NTR (red) and osteoblasts labeled 
by sp7:GFP (green) at 72 hpf. In foxc1a; foxc1b mutants, col2a1:mCherry-NTR expression is weaker 
and/or reduced in the palatoquadrate (Pq), symplectic (Sy), and hyosymplectic (Hm) domains. 
sp7:GFP+ osteoblasts of the developing opercular bone (Op, arrows) are less affected. Numbers 
indicate proportion of animals showing the displayed patterns. Scale bars = 100 μm. 
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Figure S7. Normal pectoral fins in Fox-C and Fox-F mutants  
Images show pectoral fin skeletons stained with Alcian Blue (cartilage) and Alizarin Red (bone) at 5 
dpf. No defects were seen in either foxc1a; foxc1b or foxf1; foxf2a; foxf2b mutants. The lack of 
mineralization of the Cl bone in foxc1a; foxc1b mutants is likely an indirect consequence of cardiac 
edema. Cl, cleithrum; Ed, endoskeletal disc; Sco, scapulocoracoid. Scale bar = 100 μm. 
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Table S1. TALEN/CRISPR target sequences and genotyping conditions 
 
 
Gene TALEN/CRISPR target sequences 
Mutation 
strategy Mutation type 
Genotyping primers (5’-3’) wt product 
size 
(bp) 
Restriction 
enzyme Forward Reverse 
foxc1a 
L:ATTCCGTCTCC
AGTC 
R:GCTGATGTAC
GGCA 
TALEN 
el542: 5-bp deletion 
induces frameshift 
after aa 12 (of 476) 
el543: 17-bp 
deletion induces 
frameshift after aa 
10 (of 476) 
GCATTTCAA
GCAGGATTG
TG 
CGCGTGAGA
GTACATGGT
CA 
155 BseY1 
foxc1b GGCGTTGTGCCTTATATCCC CRISPR 
el620: 101-bp 
deletion induces 
frameshift after aa 7 
(of 433) 
ACCGAAGAA
AGGGGTACG
AT 
TGTCGGATG
AGTTCTGGA
TG 
472 _ 
foxd1 
L:GCTCTCGGAG
GAGACC 
R:CACCATCATC
TCCCTC 
TALEN 
el551: 4-bp 
insertion induces 
frameshift after aa 
12 (of 343) 
AAACCCGAG
AGAGCCATG
A 
ATCTCCCTCC
CCAACCACG
T 
93 BmgB1 
foxd2 
L:CGGACAGTTC
TGCTCT 
R:CGGACAGTTC
TGCTCT 
TALEN 
el575: 14-bp 
deletion induces 
frameshift after aa 
12 (of 369) 
ACGGAACGT
GAGAGAGGA
AG 
CGCGTTCTG
GGATAGATT
GT 
198 Hpy166II 
foxf1 GGGATATAAGGCACAACGCC CRISPR 
el658: 29-bp 
deletion induces 
frameshift after aa 
45 (of 380) 
el660: 34-bp 
deletion induces 
frameshift after aa 
33 (of 380) 
GCGCAGTCC
GTTTCTAATG
A 
TGGATGGCC
ATGACAATA
AG 
281 _ 
foxf2a GGCATCCAACAGCATGCACT CRISPR 
el616: 122-bp 
deletion induces 
frameshift after aa 
25 (of 383) 
TCCAGCATTT
GCGATGACC
A 
GGGCAGCTT
GATGAAACA
CT 
566 _ 
foxf2b GGTCTTGGGCGACCGGGTAA CRISPR 
el621: 46-bp 
deletion induces 
frameshift after aa 
176 (of 429) 
TACAAACAC
GCTTCCCGTT
T 
CCGGTAGGC
GATTGATAG
TC 
304 _ 
foxl1 _ TILLING 
sa1842: premature 
stop codon is 
formed at aa 79 (of 
363) 
CAAAAACCC
CCGTACAGC
TA 
GAGAGGTTA
TGGCGGATT
GA 
164 HpyCH4III 
foxl2 GGAGGGCGGCGGTGAGCGAA CRISPR 
el615: 5-bp deletion 
induces frameshift 
after aa 112 (of 306) 
CATCCGACA
CAACCTGTC
AC 
GTGGAGGCC
TAAACGGTC
TT 
315 HphI 
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Table S2. In situ probes		
	
	
	
	
	
	
Table S3. Primers used for transgenic constructs. 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) Enzyme for linearization 
RNA 
polymerase 
foxc1a TCAGCGTGGACAACATCATG AAATACTGGTTTGGTCAAAA EcoRI T7 
foxc1b GTTCATCATGGAGCGCTTTC CGAGATAGAGGAGGCGTTTG EcoRI T7 
foxd2 AACTCCATCCGTCACAACCT AACGGACTGCTGCACTTTCT EcoRI T7 
foxf2b GGCTGGAAGAACTCTGTTCG AGTCCTTCCGTTCTCCGACT EcoRI T7 
foxl1 TATGTGTACGGTGGCGAAGT GTGTCACTCTTTACGGGCAC EcoRI T7 
dlx2b GGAACGTATGGAGCCAGCTC TCAAAAAGGCTACCCGTTTG NotI SP6 
matn4 CTTCTTCTGTCGCTGCAATG CCTCACTGCTGCTGTGTGTT NotI SP6 
Name 5’-3’ 
fgf3-B1-F GGGGACAAGTTTGTACAAAAAAGCAGGCTATGGTTATAATTCTGCTCTT 
fgf3-B2-R GGGGACCACTTTGTACAAGAAAGCTGGGTTTAAATGTCAGCCCTTCTGT 
foxc1a-B1-F GGGGACAAGTTTGTACAAAAAAGCAGGCTCCACCATGCAGGCGCGCTATTCCGT 
foxc1a-B2-R GGGGACCACTTTGTACAAGAAAGCTGGGTTCAAAATTTGCTGCAGTCAT 
foxf1-B1-F GGGGACAAGTTTGTACAAAAAAGCAGGCTCCACCATGACGGCTGAAGTGCAGCA 
foxf1-B2-R GGGGACCACTTTGTACAAGAAAGCTGGGTTCACATCACACAAGGTTTGA 
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